These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Severe type II Gaucher disease with ichthyosis, arthrogryposis and neuronal apoptosis: molecular and pathological analyses. Finn LS; Zhang M; Chen SH; Scott CR Am J Med Genet; 2000 Mar; 91(3):222-6. PubMed ID: 10756347 [TBL] [Abstract][Full Text] [Related]
24. Gaucher disease in Romanian patients: incidence of the most common mutations and phenotypic manifestations. Drugan C; Procopciuc L; Jebeleanu G; Grigorescu-Sido P; Dussau J; Poenaru L; Caillaud C Eur J Hum Genet; 2002 Sep; 10(9):511-5. PubMed ID: 12173027 [TBL] [Abstract][Full Text] [Related]
26. Gaucher disease: frequency of the N370S mutation in the Greek population. Dimitriou E; Moraitou M; Troungos C; Schulpis K; Michelakakis H Clin Genet; 2010 Aug; 78(2):195-6. PubMed ID: 20662857 [No Abstract] [Full Text] [Related]
29. Perinatal lethal phenotype with generalized ichthyosis in a type 2 Gaucher disease patient with the [L444P;E326K]/P182L genotype: effect of the E326K change in neonatal and classic forms of the disease. Chabás A; Gort L; Díaz-Font A; Montfort M; Santamaría R; Cidrás M; Grinberg D; Vilageliu L Blood Cells Mol Dis; 2005; 35(2):253-8. PubMed ID: 15967693 [TBL] [Abstract][Full Text] [Related]
30. Look before you leap. Carrier screening for type 1 Gaucher disease: difficult questions. Borry P; Clarke A; Dierickx K Eur J Hum Genet; 2008 Feb; 16(2):139-40. PubMed ID: 18043719 [No Abstract] [Full Text] [Related]
31. Gaucher disease in Colombia: mutation identification and comparison to other Hispanic populations. Pomponio RJ; Cabrera-Salazar MA; Echeverri OY; Miller G; Barrera LA Mol Genet Metab; 2005 Dec; 86(4):466-72. PubMed ID: 16185907 [TBL] [Abstract][Full Text] [Related]
32. [Biochemical and genetic diagnosis of Gaucher disease and its phenotypical heterogeneity]. Beĭer EM; Bukina TM; Tsvetkova IV Vopr Med Khim; 2000; 46(5):451-4. PubMed ID: 11204625 [TBL] [Abstract][Full Text] [Related]
33. Gaucher type 2 disease: identification of a novel transversion mutation in a French-Irish patient. Choy FY; Humphries ML; Ben-Yoseph Y Am J Med Genet; 1998 Jun; 78(1):92-3. PubMed ID: 9637431 [No Abstract] [Full Text] [Related]
34. Functional analysis of 13 GBA mutant alleles identified in Gaucher disease patients: Pathogenic changes and "modifier" polymorphisms. Montfort M; Chabás A; Vilageliu L; Grinberg D Hum Mutat; 2004 Jun; 23(6):567-75. PubMed ID: 15146461 [TBL] [Abstract][Full Text] [Related]
35. Effective cell and gene therapy in a murine model of Gaucher disease. Enquist IB; Nilsson E; Ooka A; Månsson JE; Olsson K; Ehinger M; Brady RO; Richter J; Karlsson S Proc Natl Acad Sci U S A; 2006 Sep; 103(37):13819-24. PubMed ID: 16954197 [TBL] [Abstract][Full Text] [Related]
36. Gaucher disease: report of de novo GBA mutation in a Spanish family. Alfonso P; Pocovi M; Giraldo P Blood Cells Mol Dis; 2008; 40(3):444-5. PubMed ID: 18313951 [No Abstract] [Full Text] [Related]
37. Generation of a conditional knockout of murine glucocerebrosidase: utility for the study of Gaucher disease. Sinclair GB; Jevon G; Colobong KE; Randall DR; Choy FY; Clarke LA Mol Genet Metab; 2007 Feb; 90(2):148-56. PubMed ID: 17079175 [TBL] [Abstract][Full Text] [Related]
38. Gaucher disease in Tunisia: High frequency of the most common mutations. Cherif W; Ben Turkia H; Ben Rhouma F; Riahi I; Chemli J; Kefi R; Messai H; Amaral O; Miranda MC; Caillaud C; Tebib N; Ben Dridi MF; Abdelhak S Blood Cells Mol Dis; 2009; 43(2):161-2. PubMed ID: 19553144 [No Abstract] [Full Text] [Related]